Showing results (61-70 of 149) with videos related to
Sort By:
Pageof 15
The American Journal of Cardiology|June 1, 1995
Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectorisN R Cutler, R J Anders, S S Jhee, et al.Annals of the New York Academy of Sciences|September 24, 1993
The use of the Computerized Neuropsychological Test Battery (CNTB) in an efficacy and safety trial of BMY 21,502 in Alzheimer's diseaseN R Cutler, R C Shrotriya, J J Sramek, et al.Clinical Neuropharmacology|August 1, 1995
Pramipexole in patients with early Parkinson's diseaseJ P Hubble, W C Koller, N R Cutler, et al.The Journal of Clinical Psychiatry|July 1, 1996
Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptomsJ J Sramek, M Tansman, A Suri, et al.Psychopharmacology Bulletin|May 2, 1998
Initial safety, tolerability pharmacodynamics, and pharmacokinetics of CI-1007 in patients with schizophreniaJ J Sramek, M A Eldon, E Posvar, et al.Schizophrenia Bulletin|January 1, 1996
Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawalT M Shiovitz, T L Welke, P D Tigel, et al.DICP : the Annals of Pharmacotherapy|May 1, 1991
Idioventricular rhythm: hypervagotonia associated with placeboN R Cutler, A H Heller, N M Kurtz, et al.Journal of Geriatric Psychiatry and Neurology|October 1, 1995
Evaluation of cycloserine in the treatment of Alzheimer's diseaseT D Fakouhi, S S Jhee, J J Sramek, et al.The Journal of Clinical Psychiatry|April 18, 2001
Pharmacokinetic studies of antipsychotics in healthy volunteers versus patientsN R CutlerProgress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1986
Cerebral metabolism as measured with positron emission tomography (PET) and [18F] 2-deoxy-D-glucose: healthy aging, Alzheimer's disease and Down syndromeN R CutlerPageof 15